Ikarian Capital »

Moonlake Immunot shares owned by Ikarian Capital

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $12M 201k 60.39

More positions owned by Ikarian Capital

Argenx Se Sponsored Adr (ARGX)
Krystal Biotech Call Option (KRYS)
Cytokinetics Com New (CYTK)
Alnylam Pharmaceuticals Call Option (ALNY)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Crispr Therapeutics Namen Akt (CRSP)
Eli Lilly & Co. Put Option (LLY)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS Call Option (PRTA)
Amylyx Pharmaceuticals (AMLX)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Soleno Therapeutics (SLNO)
Eyepoint Pharmaceuticals Com New (EYPT)

View all positions for Ikarian Capital

Top funds holding Moonlake Immunot

BVF
Cormorant Asset Management
venBio Select Advisor
T. Rowe Price Associates
Citadel Advisors
Federated Investors
Darwin Global Management
Holocene Advisors
Alliancebernstein
Fred Alger Management
Westfield Capital Management Company
Balyasny Asset Management
TimesSquare Capital Management
Caption Management
5AM Venture Management

View all funds holding Moonlake Immunot